ALNY vs CNP · P/E 76, rev $1.29B vs P/E 26, rev $9.36B
Alnylam Pharmaceuticals Inc (ALNY) versus CenterPoint Energy Inc (CNP) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
CenterPoint Energy Inc (CNP) is a utilities - regulated electric company listed on NYSE.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported CNP revenue for 2025-12-31 was $9.36B. Net income was $1.05B. Revenue was up 8.3% from 2024-12-31 to 2025-12-31. CNP currently screens at market cap $28.18B and trailing P/E 26.4.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. CNP currently screens at market cap $28.18B and trailing P/E 26.4.
Not investment advice. Open the ALNY and CNP stock pages for the full models.
Not investment advice.